173 related articles for article (PubMed ID: 22470354)
1. Serotonin transporter genomic biomarker for quantitative assessment of ondansetron treatment response in alcoholics.
Seneviratne C; Johnson BA
Front Psychiatry; 2012; 3():23. PubMed ID: 22470354
[TBL] [Abstract][Full Text] [Related]
2. Ondansetron reduces naturalistic drinking in nontreatment-seeking alcohol-dependent individuals with the LL 5'-HTTLPR genotype: a laboratory study.
Kenna GA; Zywiak WH; Swift RM; McGeary JE; Clifford JS; Shoaff JR; Vuittonet C; Fricchione S; Brickley M; Beaucage K; Haass-Koffler CL; Leggio L
Alcohol Clin Exp Res; 2014 Jun; 38(6):1567-74. PubMed ID: 24773166
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking.
Johnson BA; Ait-Daoud N; Seneviratne C; Roache JD; Javors MA; Wang XQ; Liu L; Penberthy JK; DiClemente CC; Li MD
Am J Psychiatry; 2011 Mar; 168(3):265-75. PubMed ID: 21247998
[TBL] [Abstract][Full Text] [Related]
4. Ondansetron and sertraline may interact with 5-HTTLPR and DRD4 polymorphisms to reduce drinking in non-treatment seeking alcohol-dependent women: exploratory findings.
Kenna GA; Zywiak WH; Swift RM; McGeary JE; Clifford JS; Shoaff JR; Fricchione S; Brickley M; Beaucage K; Haass-Koffler CL; Leggio L
Alcohol; 2014 Sep; 48(6):515-22. PubMed ID: 25212749
[TBL] [Abstract][Full Text] [Related]
5. Determination of genotype combinations that can predict the outcome of the treatment of alcohol dependence using the 5-HT(3) antagonist ondansetron.
Johnson BA; Seneviratne C; Wang XQ; Ait-Daoud N; Li MD
Am J Psychiatry; 2013 Sep; 170(9):1020-31. PubMed ID: 23897038
[TBL] [Abstract][Full Text] [Related]
6. A within-group design of nontreatment seeking 5-HTTLPR genotyped alcohol-dependent subjects receiving ondansetron and sertraline.
Kenna GA; Zywiak WH; McGeary JE; Leggio L; McGeary C; Wang S; Grenga A; Swift RM
Alcohol Clin Exp Res; 2009 Feb; 33(2):315-23. PubMed ID: 19032576
[TBL] [Abstract][Full Text] [Related]
7. Validation of serotonin transporter mRNA as a quantitative biomarker of heavy drinking and its comparison to ethyl glucuronide/ethyl sulfate: A randomized, double-blind, crossover trial.
Cornell J; Conchas A; Wang XQ; Fink JC; Chen H; Kane MA; Pilli N; Ait-Daoud N; Gorelick DA; Li MD; Johnson BA; Seneviratne C
Alcohol Clin Exp Res; 2022 Oct; 46(10):1888-1899. PubMed ID: 36031718
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled, pharmacogenetic study of ondansetron for treating alcohol use disorder.
Seneviratne C; Gorelick DA; Lynch KG; Brown C; Romer D; Pond T; Kampman K; Kranzler HR
Alcohol Clin Exp Res; 2022 Oct; 46(10):1900-1912. PubMed ID: 36055978
[TBL] [Abstract][Full Text] [Related]
9. Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial.
Johnson BA; Roache JD; Javors MA; DiClemente CC; Cloninger CR; Prihoda TJ; Bordnick PS; Ait-Daoud N; Hensler J
JAMA; 2000 Aug 23-30; 284(8):963-71. PubMed ID: 10944641
[TBL] [Abstract][Full Text] [Related]
10. Combining ondansetron and naltrexone treats biological alcoholics: corroboration of self-reported drinking by serum carbohydrate deficient transferrin, a biomarker.
Ait-Daoud N; Johnson BA; Javors M; Roache JD; Zanca NA
Alcohol Clin Exp Res; 2001 Jun; 25(6):847-9. PubMed ID: 11410720
[TBL] [Abstract][Full Text] [Related]
11. Prediction of serotonergic treatment efficacy using age of onset and Type A/B typologies of alcoholism.
Roache JD; Wang Y; Ait-Daoud N; Johnson BA
Alcohol Clin Exp Res; 2008 Aug; 32(8):1502-12. PubMed ID: 18565156
[TBL] [Abstract][Full Text] [Related]
12. Combining ondansetron and naltrexone reduces craving among biologically predisposed alcoholics: preliminary clinical evidence.
Ait-Daoud N; Johnson BA; Prihoda TJ; Hargita ID
Psychopharmacology (Berl); 2001 Feb; 154(1):23-7. PubMed ID: 11292002
[TBL] [Abstract][Full Text] [Related]
13. Combining ondansetron and naltrexone effectively treats biologically predisposed alcoholics: from hypotheses to preliminary clinical evidence.
Johnson BA; Ait-Daoud N; Prihoda TJ
Alcohol Clin Exp Res; 2000 May; 24(5):737-42. PubMed ID: 10832917
[TBL] [Abstract][Full Text] [Related]
14. Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics.
Javors MA; Seneviratne C; Roache JD; Ait-Daoud N; Bergeson SE; Walss-Bass MC; Akhtar FZ; Johnson BA
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):7-13. PubMed ID: 15610939
[TBL] [Abstract][Full Text] [Related]
15. Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking?
Johnson BA; Javors MA; Roache JD; Seneviratne C; Bergeson SE; Ait-Daoud N; Dawes MA; Ma JZ
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):209-16. PubMed ID: 17950969
[TBL] [Abstract][Full Text] [Related]
16. Ondansetron reduces mood disturbance among biologically predisposed, alcohol-dependent individuals.
Johnson BA; Ait-Daoud N; Ma JZ; Wang Y
Alcohol Clin Exp Res; 2003 Nov; 27(11):1773-9. PubMed ID: 14634493
[TBL] [Abstract][Full Text] [Related]
17. Ondansetron reduces the craving of biologically predisposed alcoholics.
Johnson BA; Roache JD; Ait-Daoud N; Zanca NA; Velazquez M
Psychopharmacology (Berl); 2002 Apr; 160(4):408-13. PubMed ID: 11919668
[TBL] [Abstract][Full Text] [Related]
18. Low-dose ondansetron: A candidate prospective precision medicine to treat alcohol use disorder endophenotypes.
Johnson B; Alho H; Addolorato G; Lesch OM; Chick J; Liu L; Schuyler V
Eur J Intern Med; 2024 Jun; ():. PubMed ID: 38876929
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism in the serotonin transporter gene and response to treatment in African American cocaine and alcohol-abusing individuals.
Mannelli P; Patkar AA; Murray HW; Certa K; Peindl K; Mattila-Evenden M; Berrettini WH
Addict Biol; 2005 Sep; 10(3):261-8. PubMed ID: 16109588
[TBL] [Abstract][Full Text] [Related]
20. Effects of ondansetron in early- versus late-onset alcoholics: a prospective, open-label study.
Kranzler HR; Pierucci-Lagha A; Feinn R; Hernandez-Avila C
Alcohol Clin Exp Res; 2003 Jul; 27(7):1150-5. PubMed ID: 12878921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
